← Back
$GENB All transactions

Generate Biomedicines, Inc.

C

$ Value

$0

Shares

1,000,000

Price

$0

Filed

Mar 2

Insider

Name

Nally Michael

Title

Chief Executive Officer

CIK

0001763945

Roles

Director Officer

Transaction Details

Transaction Date

2026-03-02

Code

C

Table

Derivative

Ownership

Indirect

Equity Swap

No

Shares After

Footnotes

Each share of Series A Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-1.5190 basis upon the closing of the Issuer's initial public offering on March 2, 2026. The Series A Preferred Stock had no expiration date. | The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose. | The shares underlying this option shall vest in two equal installments on each of February 19, 2029 and February 19, 2030, subject to the Reporting Person's continued service on each such vesting date. | The shares underlying this option shall vest in forty-eight equal monthly installments following February 19, 2026, subject to the Reporting Person's continued service on each such vesting date.

Filing Info

Accession No.

0001193125-26-085883

Form Type

4

Issuer CIK

0002100782

Nally Michael's History

Date Ticker Type Value
2026-04-16 PPG A $0
2026-04-15 PPG M $0
2026-04-15 PPG M $199K
2026-03-12 PPG A $7K
2026-03-04 GENB $240K
2026-03-02 GENB C
2026-03-02 GENB C $0
2026-02-26 GENB A $0
2026-02-26 GENB A $0
2025-12-12 PPG A $8K

Other Insiders at GENB (90d)

Insider Bought Sold Last
AFEYAN NOUBAR $150.0M 2026-03-02
Nally Michael
Chief Executive Officer
$240K 2026-03-04
Silvers Jason
President & CFO
$32K 2026-03-02
Mendillo Jane L $24K 2026-03-02
Grous Beth
Chief People Officer
$5K 2026-03-02
Fanucci Marsha 2026-02-26
Simonian Nancy A 2026-02-26
Bancel Stephane 2026-03-02
Martin Sean
Chief Legal Officer & GC
2026-02-26
ARNOLD FRANCES 2026-02-26
Vessey Rupert 2026-02-26
Parker Paul Gray 2026-02-26
Grigoryan Gevorg
Chief Technology Officer
2026-02-26
Lee Laurie Anne
Chief Medical Officer
2026-02-26